Navigation Links
Synteract Leadership to Provide Insights at Industry Events on Both West and East Coasts
Date:9/13/2012

SAN DIEGO and BOSTON, Sept. 13, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be presenting at two upcoming North America conferences, Outsourcing in Clinical Trials – New England and BIOCOM Pharmaceutical Outsourcing Workshop.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

The Outsourcing in Clinical Trials – New England conference will take place September 24 - 26, 2012, in Boston. Synteract's Joanna Dojillo, M.Sc., Project Manager, will present at 10:30 a.m. EDT, Tuesday, September 25th. She will present, "Applying result-driven rescue techniques to successfully transition (and save) a failing study," including:

  • Determining when your current service provider is not performing to expectations and how to successfully select a new CRO
  • Assessing the complexity and current status of a project
  • Developing a collaborative relationship between the CRO and sponsor
  • Analyzing transition needs and identifying clear goals and objectives regarding regulatory approval, enrollment options, data management
  • Orchestrating the rescue to efficiently meet timelines and sponsor expectations

As a sponsor of the event, Synteract will also be located at booth #57 and available to discuss the company's Shared Work – Shared Vision approach – it's the way they do business.

The BIOCOM Pharmaceutical Outsourcing Workshop will be held Thursday, September 20th from 8:00 a.m. - 5:30 p.m. PDT in San Diego. Synteract's Rod Saponjic, PhD, MBA, senior vice president, global project management, will present at 3:15 p.m. PDT, discussing "Best Case Planning for Partnered Development."  Comprised of sponsor, site, and provider participants, the panel will examine these various perspectives:

  • Utilizing best case planning for establishing R&D objectives, with a critical focus on establishing and managing development partner/CRO expectations
  • Implications of best case planning will be examined from investor, board, C-Suite, investigative site and project team perspectives 
  • Examining insights into managing project and partner expectations for shared program success  
  • Evaluating alternatives regarding contingency planning and the true costs of drug development in a partnering structure

"Having supported the clinical development needs of pharma and biotech companies across a range of therapeutic areas for nearly two decades, we are known for providing expertise and customized services through a collaborative approach," explained Stewart Bieler, chief operating officer. "While participating in these industry thought leader forums, we're pleased to share our experience and knowledge, while at the same time keeping our pulse on market trends so we continue to deliver what our clients value."

To set up an appointment in advance of Outsourcing in Clinical Trials – New England, please contact Megan O'Keefe, business development director, at 917.692.8047 or mokeefe@synteract.com. To register for BIOCOM Pharmaceutical Outsourcing Workshop, visit its site.

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract Senior Director Olivia Montano Honored as One of the PharmaVOICE 100
2. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
3. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
4. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
5. H. D. Smith Names Timothy Booth Corporate VP, Home Healthcare (HHC), In First-of-its-Kind Leadership Appointment
6. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
7. WebMD Taps David C. Marek to Assume Consumer Leadership Role
8. Anaptysbio Expands Leadership Team With Addition Of Dr. Andrew J. Mcknight
9. Henry Schein Cares Supports Alliance for Oral Health Across Borders Leadership Event
10. Paragon Bioservices, Inc. Wins The 2012 CMO Leadership Award
11. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the ... heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to solving ... Countless deodorants flood the aisles that contain harmful chemicals that should be put ...
(Date:4/27/2017)... ... , ... Goodcents Deli Fresh Subs announced a franchise expansion agreement today including ... , The first new location will open at the corner of 27th and Randolph ... Lights Drive this fall. And the third location is in the process of being ...
(Date:4/26/2017)... ... 2017 , ... Jump Technologies, Inc., an innovative software company ... a round of funding to accelerate its growth strategies. The $3.5 million investment ... a growth equity firm focused on investments in healthcare and technology companies. This ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... the adoption of e-prescribing as measured in Part D Medicare data. The dataset, ... to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") ...
Breaking Medicine News(10 mins):